A Novel Oral Natural Extract for the Treatment of Senile Purpura
Status unconfirmed · Not applicable · Has a placebo group
Conditions studied: PURPURA
In brief
A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.
Key facts
- Study ID
- NCT01183910
- Run by
- Nexgen Dermatologics, Inc.
- People needed
- 75
- Starts
- 2008-11-01
- Expected to finish
- 2011-08-01
- Last updated by the study team
- 2011-06-08
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients with evidence of purpura on physical exam
You may not qualify if…
- Preexisting condition that would not allow the patients to take oral calcium supplement
Where it is running
- Berlin Center of Medical Aesthetics — Boynton Beach, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.